CeMM International Postdoc Program (Vienna, Austria)

Pre-ERC Postdoc Program in Cellular, Molecular and Digital Medicine

We are recruiting a group of postdocs (13 positions available) who are eager to pursue groundbreaking biomedical research, and we will help them to establish themselves asfuture scientific leaders. This postdoc program is designed to prepare postdoctoral researchers for a successful ERC Starting Grant application and for an independent research career in top research organizations in Europe and around the world.

The postdoc program is based at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences in Vienna, one of Europe’s leading centers for basic biomedical research – with clinical translation in mind. Selected candidates will join one of CeMM’s research groups for 3 to 6 years, addressing ambitious research questions in areas such as cancer, immunology, chemical biology, epigenetics, metabolism, and genomic medicine. Research projects will focus on medically relevant problems, including disease mechanisms, modern therapeutics and diagnostic strategies. On top, postdocs will receive extensive career development and leadership training from the entire CeMM Faculty and additional experts in a highly collaborative and supportive environment.

Potential projects:

Host pathogen interactions (Bergthaler Lab); Mechanistic investigations of the dynamic evolution of chronic viruses

Immunometabolism (Bergthaler Lab); Metabolic inter-organ communication during inflammation and infection

Cancer immune modeling (Bock Lab); Single-cell analysis of immune deregulation in (humanized) mouse models of cancer

Human synthetic biology (Bock Lab); Developing new cell-based therapies (CAR T etc.) using combinatorial bioengineering and machine learning / artificial intelligence

Precision pediatric oncology (Boztug Lab); Integrating multi-omics profiling with ex vivo image-based drug sensitivity testing for personalized therapies

Organoid-omics (Boztug Lab); Profiling patient organoids from inherited rare diseases and pediatric cancer patients for precision medicine

Chemical epigenetics (Kubicek Lab); Developing novel chemical probes targeting cancers with mutations in chromatin modifiers

Nuclear metabolism (Kubicek Lab); Studying the role of chromatin-bound metabolic enzymes in leukemias

Cellular transporters (Superti-Furga Lab); Targeting cellular transporters to modulate disease

Systems biology (Superti-Furga Lab); Network-based systems-level analysis of the human transportome

Cancer biology (Villunger Lab); Interrogating the PIDDosome in ploidy control for tumor suppression

Polyploidization in health and disease (Villunger Lab); The role of polyploidy in heart development and regeneration

Targeted protein degradation (Winter Lab); Medicinal chemistry strategies to modulate the proteolytic machinery for cancer therapy

We are open to other ideas that fit into the broader scope and mission of the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and its partner institute LBI-RUD, the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases.

More information, and a more detailed description of the #CeMMPostdocProgram
Deadline for applications: 31 August 2019

Apply Now

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.